Skip to content
OpenSampling

2021 · Analytical science advances · open access

Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA)

Knoop et al.

The finding, in our words

Dried blood spot specimens collected at home without medically trained personnel showed agreement with conventional venous blood when analysed by electrochemiluminescence immunoassay, with stable antibody readouts over more than 200 days of dry dark storage and consistent results in individuals tested twice within 10 months post-infection.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2026

    The study validated a semi-quantitative protocol for Epstein-Barr virus serology using dried blood spots, demonstrating 98.8% sensitivity and 96.5% specificity compared to paired venous serum samples. The successful validation in a self-sampling cohort confirms the suitability of this patient-centric microsampling approach for large-scale seroprevalence studies and decentralised trials.

    A dried blood spot protocol for high-throughput semi-quantitative analysis of Epstein-Barr Virus VCA IgG and EBNA IgG serologies based on the Roche Elecsys systemRubio-Acero et al., Virology journal · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology
  2. 2024

    Self-collected dried blood spots analysed on the Roche Elecsys platform gave quantitative anti-spike antibody results that agreed closely with paired venous samples, with sensitivity 96.63% and specificity 97.81% and a conversion formula across 0.018 to 250 U/mL, enabling accurate tracking of titre changes in longitudinal cohorts after vaccination.

    A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys systemCastelletti et al., Microbiology spectrum · source ↗

    • blood
    • dried
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology
  3. 2023

    Dried blood spot eluates showed high agreement with serum for SARS-CoV-2 IgG against Spike and Nucleocapsid (r≈0.96; qualitative φ≈0.98–1.0) and remained stable after 6–8 hours of storage, supporting use of capillary DBS for serosurveys and decentralised testing.

    Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid proteinGuttmann et al., Biochemistry and biophysics reports · source ↗

    • venous-agreement
    • blood
    • dbs
    • self-collection
    • dried
    • serology
    • capillary
    • validation
  4. 2023

    In 1070 young adults, dried blood spot eluates correlated strongly with serum for anti-spike IgGAM and total IgG, IgA and IgM; labDBS achieved 82.0% sensitivity and 98.2% specificity and ssDBS 86.1% sensitivity and 96.7% specificity versus serum, with minimal difference between self and investigator collection.

    Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adultsFerentinos et al., Journal of immunological methods · source ↗

    • blood
    • dried
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology
  5. 2022

    Dried blood spot sampling achieved high sensitivity and specificity for SARS-CoV-2 antibody detection with strong correlation to paired serum, enabling virtually painless, decentralised specimen collection in community and remote settings where venepuncture is difficult.

    Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infectionCatlett et al., Journal of clinical virology plus · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology